Status:
COMPLETED
Study of Circulating Markers in Serum of Patients Treated for Metastatic Colorectal Cancer
Lead Sponsor:
University Hospital, Rouen
Conditions:
Metastatic Colorectal Cancer
Eligibility:
All Genders
18-95 years
Phase:
NA
Brief Summary
The primary purpose of the study is to confirm the results of previous study about the usefulness of the serum Carcinoembryonic antigen (CEA) kinetic for chemotherapy monitoring in patients with unres...
Detailed Description
Prospective cohort study of patients treated with systemic chemotherapy for unresectable metastatic colorectal cancer. The chemotherapy monitoring is currently based on radiological evaluation (RECIST...
Eligibility Criteria
Inclusion
- Patient has Stage IV colorectal adenocarcinoma histologically proved
- Patient has at least one measurable lesion
- Patient has performance status 0-2 on the WHO performance scale
- Patient is male or female, and \> 18 years of age
- Patient has agree to participate by giving written informed consent
Exclusion
- Patient has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the study.
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01212510
Start Date
October 1 2010
End Date
July 1 2016
Last Update
August 17 2016
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre François Baclesse
Caen, France, 14000
2
University Hospital
Caen, France, 14000
3
Centre Frédéric Joliot
Rouen, France, 76000
4
University Hospital
Rouen, France, 76000